David M. Knott Jr’s Orchestra BioMed OBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58M Hold
253,651
– – 0.86% 23
2026
Q2
$1.09M Hold
253,651
– – 0.58% 33
2026
Q1
$1.08M Buy
253,651
+3,651
+1% +$15.5K 0.64% 32
2025
Q4
$1.04M Buy
250,000
+55,000
+28% +$222K 0.48% 34
2025
Q3
$484K Buy
195,000
+95,000
+95% +$262K 0.2% 54
2025
Q2
$268K Buy
+100,000
New +$292K 0.12% 53

Other funds holding OBIO

David M. Knott Jr's OBIO Position: Q3 2026 in Review

David M. Knott Jr held its Orchestra BioMed (OBIO) position steady in Q3 2026 at 253,651 shares worth $1.58M. The position accounts for 0.86% of the portfolio, ranked #23.

David M. Knott Jr first reported a position in OBIO in Q2 2025 and has held it in 6 quarters since. 93 funds tracked by Wall St. Rank hold OBIO as of Q3 2026.

  • David M. Knott Jr held 253,651 shares of Orchestra BioMed worth $1.58M as of Q3 2026.
  • David M. Knott Jr left its Orchestra BioMed share count unchanged in Q3 2026.
  • Orchestra BioMed made up 0.86% of David M. Knott Jr's portfolio in Q3 2026, its #23 holding.
  • David M. Knott Jr first reported a position in Orchestra BioMed in Q2 2025 and has held it in 6 quarters since.
  • 93 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2026.

Based on David M. Knott Jr's 13F filing for Q3 2026, filed 12 Nov 2026.